Sorry, you need to enable JavaScript to visit this website.

BESPONSA™ (inotuzumab ozogamicin) Indications and Usage

1. INDICATIONS AND USAGE

BESPONSA is indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No